Results 1 to 10 of about 61,183 (295)

Cancer cachexia

Zdravniški Vestnik, 2013
The present article presents the Slovenian multidisciplinary agreement statement on the definition, staging, clinical classification and multimodal approach to the treatment of cachexia in cancer patients.
Nada Rotovnik Kozjek, Živa Mrevlje, Barbara Koroušič Seljak, Katja Kogovšek, Branko Zakotnik, Iztok Takač, Matjaž Horvat, Tadej Dovšak, Vojko Didanović, Andrej Kansky, Jožica Červek, Vanja Velenik, Franc Anderluh, Milena Kerin, Matjaž Sever, Primož Strojan, Borut Štabuc, Mojca Unk, Jernej Benedik, Erik Brecelj, Tadeja Pintar, Lidija Kompan, Marko Novak, Laura Petrica, Denis Mlakar Mastnak, Brigita Avramović Brumen, Eva Peklaj, Rajmonda Jankovič, Urška Jelenko, Edita Rotner, Sanja Đukić, Petra Tavčar   +31 more
doaj   +2 more sources

Exploring the potential of ginseng-derived compounds in treating cancer cachexia [PDF]

Journal of Ginseng Research
Cancer cachexia is a complex wasting syndrome characterized by significant loss of body weight and muscle mass in patients with advanced cancer. The disease is associated with increased systemic inflammation, altered neurohormonal signaling, and, in ...
Phuong Thi Ho, Ika Agus Rini, Phuong Thi Hoang, Taek Kyun Lee, Sukchan Lee   +4 more
doaj   +2 more sources

Cancer cachexia

Journal of Oral and Maxillofacial Pathology, 2011
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. The signs and symptoms of cachexia are considered as the prognostic parameters in cancer patients.
Dhanapal, Raghu, Saraswathi, TR, Govind, Rajkumar N   +2 more
  +14 more sources

Screening Assessment and Therapy Intervention of Cancer Cachexia in Adult Patients——Based on the Interpretation of Cancer Cachexia in Adult Patients: ESMO Clinical Practice Guidelines [PDF]

Zhongguo quanke yixue, 2023
Cancer cachexia is a cancer-related, multi-factorial, irreversible clinical syndrome characterized by progressive nutritional consumption, which greatly reduces the survival expectation and quality of life of cancer patient.
WANG Rui, WANG Xiaomei, PENG Guoqing, YU Huan, WANG Sihan, XIA Jin
doaj   +1 more source

Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer‐induced cachexia

JCSM Rapid Communications, 2022
Background Cancer patients who exhibit cachexia lose weight and have low treatment tolerance and poor outcomes compared with cancer patients without weight loss.
Jeffery M. Chakedis, Mary E. Dillhoff, Carl R. Schmidt, Priyani V. Rajasekera, David C. Evans, Terence M. Williams, Denis C. Guttridge, Erin E. Talbert   +7 more
doaj   +1 more source

Cancer cachexia

Journal of Parenteral and Enteral Nutrition, 1988
Cancer cachexia describes a syndrome of progressive weight loss, anorexia, and persistent erosion of host body cell mass in response to a malignant growth. Although often associated with preterminal patients bearing disseminated disease, cachexia may be present in the early stages of tumor growth before any signs or symptoms of malignancy. A decline in
K A, Kern, J A, Norton
  +8 more sources

Targeting cancer cachexia: Molecular mechanisms and clinical study

MedComm, 2022
Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia,
Yong‐Fei Wang, Zi‐Yi An, Dong‐Hai Lin, Wei‐Lin Jin   +3 more
doaj   +1 more source

Cancer cachexia [PDF]

QJM: An International Journal of Medicine, 2005
Cancer cachexia is a severe debilitating disorder for which there are currently few therapeutic options. It is driven by the release of pro-inflammatory cytokines and cachectic factors by both host and tumour. Over the past few years, basic science advances have begun to reveal the breadth and complexity of the immunological mechanisms involved, and in
J N, Gordon, S R, Green, P M, Goggin
openaire   +2 more sources

Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study

Journal of Cachexia, Sarcopenia and Muscle, 2021
Backgrounds Hand grip strength (HGS) is one of diagnose criteria factors of sarcopenia and is associated with the survival of patients with cancer. However, few studies have addressed the association of HGS and 1 year mortality of patients with cancer ...
Mengmeng Song, Qi Zhang, Meng Tang, Xi Zhang, Guotian Ruan, Xiaowei Zhang, Kangping Zhang, Yizhong Ge, Ming Yang, Qinqin Li, Xiangrui Li, Xiaoyue Liu, Wei Li, Minghua Cong, Kunhua Wang, Chunhua Song, Hanping Shi   +16 more
doaj   +1 more source

Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study

OncoImmunology, 2021
Although previous studies suggest that cancer cachexia is a poor prognostic factor for immune checkpoint inhibitor monotherapy, the impact of cancer cachexia on chemoimmunotherapy is unclear.
Kenji Morimoto, Junji Uchino, Takashi Yokoi, Takashi Kijima, Yasuhiro Goto, Akira Nakao, Makoto Hibino, Takayuki Takeda, Hiroyuki Yamaguchi, Chieko Takumi, Masafumi Takeshita, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama   +18 more
doaj   +1 more source